Carl Zeiss Meditec (ETR:AFX) has been assigned a €77.50 ($90.12) price objective by equities researchers at Independent Research in a report released on Tuesday, Borsen Zeitung reports. The firm presently has a “sell” rating on the stock. Independent Research’s price target indicates a potential downside of 13.75% from the company’s current price.
A number of other research firms have also issued reports on AFX. Kepler Capital Markets set a €62.00 ($72.09) price target on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a research report on Tuesday, January 15th. Berenberg Bank set a €68.00 ($79.07) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research report on Friday, January 18th. Nord/LB set a €86.00 ($100.00) price target on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research report on Monday, January 21st. Hauck & Aufhaeuser set a €78.50 ($91.28) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research report on Thursday, January 24th. Finally, Deutsche Bank set a €71.00 ($82.56) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research report on Tuesday, February 12th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Carl Zeiss Meditec currently has a consensus rating of “Hold” and an average target price of €74.88 ($87.06).
AFX stock opened at €89.85 ($104.48) on Tuesday. The company has a market capitalization of $7.96 billion and a P/E ratio of 63.54. Carl Zeiss Meditec has a 52 week low of €55.75 ($64.83) and a 52 week high of €88.85 ($103.31).
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Featured Story: Buyback
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.